Author/Authors :
Singh Sunita نويسنده , Gupta Sumiti نويسنده Department of Pathology and Gynecology, Pt. B.D Sharma Post Graduate University of Medical Sciences, Rohtak, Haryana, India , Sen Rajeev نويسنده Department of Pathology, Pt B D Sharma UHS, Rohtak, Haryana, India , Malik Shivani نويسنده Department of Pathology, Pt B D Sharma UHS, Rohtak, Haryana, India , Kalra Rajnish نويسنده Department of Pathology, Pt B D Sharma UHS, Rohtak, Haryana, India , Bansal Vipul نويسنده Department of Radiotherapy, Pt B D Sharma UHS, Rohtak, Haryana, India
Abstract :
Follicular dendritic cell neoplasms are extremely rare. Information regarding the
accurate treatment and prognosis is limited owing to their rarity; thus, this tumor
encompasses a domain to be brought into focus. Clinical and pathological diagnoses
warrant a high index of suspicion as this entity is not considered in routine clinical
practice. Histopathologically it mimics various other neoplasms which lead to higher
chances of misdiagnosis at initial evaluation. Use of follicular dendritic cell immunohistochemical
markers CD 21 and CD 35 helps in rendering a definitive diagnosis.
